<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>John Klein - Community-Engaged Founder of Cambridge Therapeutics by John Klein New Jersey</title>
      <link>https://padlet.com/JohnKleinNewJersey/About</link>
      <description>Founder of two pharmaceutical firms, Dava Pharmaceutical Company and Cambridge Therapeutics, John Klein has amassed a long list of achievements over his career in healthcare. His success in increasing the value of companies won recognition from such outlets as Wall Street Transcripts and Mitchell &amp; Co. Forbes honored Cambridge Therapeutics’ John Klein as a leading CEO, while Business Week awarded him the Corporate Turnaround of the Year honor for his work at Zenith Laboratories.

John Klein’s accomplishments as an executive extend beyond the financial realm. He has had a hand in receiving FDA approval for more than 300 generic drugs and 400 supplements. A sought-after expert, he has advised and performed as a consultant to Harvard Business School and Silicon Valley firm Knowledge Consultants.

Outside of his career, John Klein has served as trustee and president of Dwight-Englewood School and trustee of Hackensack Meridian Health. He received the Ellis Island Medal of Honor, a prestigious award whose recipients include US presidents, world leaders, and Nobel Prize winners, in recognition of his dedication to community service.</description>
      <language>en-us</language>
      <pubDate>2018-09-27 09:26:37 UTC</pubDate>
      <lastBuildDate>2025-12-29 18:20:12 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url></url>
      </image>
      <item>
         <title>MedAxiom Partners with Cambridge Therapeutic Technologies to Offer Patient-Centric Medication Adherence Solution to Cardiovascular Practices | VentureBeat</title>
         <author>JohnKleinNewJersey</author>
         <link>https://padlet.com/JohnKleinNewJersey/About/wish/286407786</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://venturebeat.com/2016/09/07/medaxiom-partners-with-cambridge-therapeutic-technologies-to-offer-patient-centric-medication-adherence-solution-to-cardiovascular-practices/" />
         <pubDate>2018-09-27 09:27:47 UTC</pubDate>
         <guid>https://padlet.com/JohnKleinNewJersey/About/wish/286407786</guid>
      </item>
      <item>
         <title>MedAxiom Partners with Cambridge Therapeutic Technologies to Offer Patient-Centric Medication Adherence Solution to Cardiovascular Practices | Business Wire</title>
         <author>JohnKleinNewJersey</author>
         <link>https://padlet.com/JohnKleinNewJersey/About/wish/286407887</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.businesswire.com/news/home/20160907006065/en/MedAxiom-Partners-Cambridge-Therapeutic-Technologies-Offer-Patient-Centric" />
         <pubDate>2018-09-27 09:28:04 UTC</pubDate>
         <guid>https://padlet.com/JohnKleinNewJersey/About/wish/286407887</guid>
      </item>
   </channel>
</rss>
